+992.6%
HOOD vs GSK
+53.4%
+939.1%
-57.3%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.9% | -2.7% | -1.2% | -3.8% |
| 7D | +13.4% | -4.2% | +17.5% | +13.5% |
| 30D | +25.8% | -7.5% | +33.3% | +25.9% |
| 3M | +38.0% | -3.3% | +41.3% | +38.2% |
| 6M | +52.2% | -9.3% | +61.5% | +52.4% |
| YTD | +3.7% | +1.6% | +2.2% | +4.5% |
| 1Y | +0.1% | +25.5% | -25.4% | +1.0% |
| 3Y | +992.6% | +49.3% | +943.3% | +937.1% |
| All | +992.6% | +53.4% | +939.1% | +937.1% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling